Kopran Ltd share price logo

Kopran Share Price

(KOPRAN)

₹184.770.62%

as on 04:02PM, 21 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Kopran Performance

  • Day's Low

    Day's High

    ₹182.01
    Day's Price Range
    ₹192.9
  • 52 Week's Low

    52 Week's High

    ₹157.56
    52-Week Price Range
    ₹369.7
1 Month Return-8.33 %
3 Month Return-15.82 %
1 Year Return-29.11 %
Previous Close₹185.92
Open₹184.70
Volume58.57K
Upper Circuit-
Lower Circuit-
Market Cap₹897.73Cr

Kopran Key Statistics

P/E Ratio

18.88

PEG Ratio

12.93

Market Cap

₹897.73 Cr

P/B Ratio

2.99

EPS

10.57

Dividend Yield

1.16

Sector

Pharmaceuticals

ROE

8.53

Kopran Mutual Fund Holdings

Key events for Kopran Ltd

  • Kopran Reports Decline in Sales and Profit - 17 Feb, 2025

    Kopran's standalone net sales for December 2024 fell by 12.63% to Rs 71.94 crore. Net profit decreased by 12.97% to Rs 7.41 crore, with EBITDA down 9.06%. The stock has seen significant declines, with -39.37% returns over the last 6 months.
  • Kopran Reports Decline in Net Profit for December Quarter - 11 Feb, 2025

    Kopran Ltd reported a 34.14% decline in consolidated net profit to Rs 10.40 crore for the December 2024 quarter, compared to Rs 15.79 crore in December 2023. However, sales increased by 4.61% to Rs 166.24 crore from Rs 158.92 crore in the previous year.

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KOPRAN stock has moved up by 7.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 142.06 Cr → 166.41 Cr (in ₹), with an average increase of 7.6% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 53.97% to 54.67% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 7.38 Cr → 10.4 Cr (in ₹), with an average increase of 29.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 57.9% return, outperforming this stock by 87.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.1% return, outperforming this stock by 155.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.32% to 0.86% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 44.49% to 44.45% in Dec 2024 quarter

Kopran Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹158.92Cr (-)₹186.08Cr (↑17.09%)₹139.44Cr (↓25.06%)₹151.56Cr (↑8.69%)₹166.24Cr (↑9.69%)
Net Income₹15.79Cr (-)₹18.62Cr (↑17.92%)₹11.10Cr (↓40.39%)₹7.38Cr (↓33.51%)₹10.40Cr (↑40.92%)
Net Profit Margin9.94% (-)10.01% (↑0.70%)7.96% (↓20.48%)4.87% (↓38.82%)6.26% (↑28.54%)
Value in ₹ crore
Details2021202220232024
Total Assets₹326.35Cr (-)₹465.44Cr (↑42.62%)₹507.35Cr (↑9.00%)₹512.52Cr (↑1.02%)
Total Liabilities₹79.50Cr (-)₹86.72Cr (↑9.08%)₹111.76Cr (↑28.87%)₹95.65Cr (↓14.41%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹9.97Cr (-)₹48.77Cr (↑389.17%)-₹37.80Cr (↓177.51%)₹16.87Cr (↓144.63%)₹34.96Cr (↑107.23%)

Index Inclusions

BSE Healthcare

₹39,619.96

-1.6 (-643.73%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹45,856.00

-0.43 (-198.94%)

Kopran Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
44.45%
-0.08
Foreign Institutions
0.86%
-34.34
Mutual Funds
0%
14.81
Retail Investors
54.67%
1.30
Others
0%
-98.72

Kopran Key Indicators

Details20202021202220232024
Return On Assets %6.3418.8813.115.379.94
Details20202021202220232024
Book Value Per Share (₹)43.8656.6588.491.11101.9
Details20202021202220232024
Earning Per Share (₹)4.8614.2412.665.6510.57
Details20202021202220232024
Return On Equity %5.019.853.758.078.53

Kopran Valuation

Kopran in the last 5 years

  • Overview

  • Trends

Lowest (3.00x)

March 24, 2020

Today (18.88x)

February 20, 2025

Industry (51.76x)

February 20, 2025

Highest (53.33x)

September 5, 2023

LowHigh

Kopran Earnings and Dividends

  • Kopran Ltd Earnings Results

    Kopran Ltd’s net profit fell -34.14% since last year same period to ₹10.40Cr in the Q3 2024-2025. On a quarterly growth basis, Kopran Ltd has generated 40.92% jump in its net profits since last 3-months.

    Read More about Earnings Results

Kopran Technicals Summary

Bearish

Neutral

Bullish

Neutral

Kopran Ltd is currently in a Neutral trading position according to technical analysis indicators.

Kopran Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹897.73 Cr109.89%0.53₹50 Cr₹614 Cr
NA₹181.11 Cr-3.44%0.96NANA
NA₹42.63 Cr6.79%0.58NANA
NA₹2,091.41 Cr42.75%0.65-₹2 Cr₹559 Cr
NA₹1,130.58 Cr43.88%0.50₹93 Cr₹580 Cr

About Kopran

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Share Price: ₹184.77 per share as on 21 Feb, 2025 04:02 PM
Market Capitalisation: ₹897.73Cr as of today
Revenue: ₹166.24Cr as on December 2024 (Q4 24)
Net Profit: ₹10.40Cr as on December 2024 (Q4 24)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
OrganisationKopran
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Kopran Ltd

What is Kopran Ltd price today?

Kopran Ltd share price today stands at ₹184.77, Open: ₹184.7, Previous Close: ₹185.92, High: ₹192.9, Low: ₹182.01, 52 Week High: ₹369.7, 52 Week Low: ₹157.56.

How to Buy Kopran Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Kopran Ltd shares

Is Kopran Ltd listed on NSE?

Kopran Ltd is listed on NSE

Is Kopran Ltd listed on BSE?

Kopran Ltd is listed on BSE

What are today's High and Low prices of Kopran Ltd?

  • Today's highest price of Kopran Ltd is ₹192.9.
  • Today's lowest price of Kopran Ltd is ₹182.01.

What are today's traded volumes of Kopran Ltd?

Today's traded volume of Kopran Ltd(KOPRAN) is 58.57K.

What is today's market capitalisation of Kopran Ltd?

Today's market capitalisation of Kopran Ltd(KOPRAN) is ₹897.73Cr.

What is the 52 Week High and Low Range of Kopran Ltd?

Kopran Ltd (KOPRAN)
Price
52 Week High
₹369.7
52 Week Low
₹157.56

How much percentage Kopran Ltd is down from its 52 Week High?

Kopran Ltd (KOPRAN) share price is ₹184.77. It is down -50.02% from its 52 Week High price of ₹369.7

How much percentage Kopran Ltd is up from its 52 Week low?

Kopran Ltd (KOPRAN) share price is ₹184.77. It is up 17.27% from its 52 Week Low price of ₹157.56

What are the historical returns of Kopran Ltd?

Kopran Ltd (KOPRAN)
Returns
1 Day Returns
-1.15%
1 Month Returns
-8.33%
3 Month Returns
-15.82%
1 Year Returns
-29.11%

What is the PE ratio of Kopran Ltd today?

PE Ratio of Kopran Ltd is 18.88

PE ratio = Kopran Ltd Market price per share / Kopran Ltd Earnings per share